Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Allogeneic and autologous haptenised and irradiated cells and cell lysates derived from glioma

EU orphan designation number: EU/3/13/1211   
Active ingredient: Allogeneic and autologous haptenised and irradiated cells and cell lysates derived from glioma
Indication: Treatment of glioma
Sponsor: ERC Belgium
Scientific Park Crealys, Rue Jean Sonet 10, 5032 Isnes, Belgique

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/12/2013 Centralised Orphan - Designation EMA/OD/107/13 (2013)9699 of 18/12/2013